SunWay Biotech Co., LTD. (TPEX:1271)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.60
-0.50 (-0.70%)
Oct 9, 2025, 2:29 PM CST

SunWay Biotech Co., LTD. Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
4,2634,7284,5681,5982,041-
Upgrade
Market Cap Growth
-20.23%3.52%185.85%-21.71%--
Upgrade
Enterprise Value
4,1294,6934,5671,1541,698-
Upgrade
Last Close Price
70.6076.54128.3142.6951.22-
Upgrade
PE Ratio
50.4239.8899.1053.1912.10-
Upgrade
PS Ratio
4.484.878.003.765.37-
Upgrade
PB Ratio
1.321.451.435.553.73-
Upgrade
P/TBV Ratio
5.165.606.145.893.84-
Upgrade
P/FCF Ratio
42.66116.10468.6637.5213.51-
Upgrade
P/OCF Ratio
21.0130.1381.5937.5212.70-
Upgrade
EV/Sales Ratio
4.344.848.002.714.46-
Upgrade
EV/EBITDA Ratio
22.1424.9471.6126.099.59-
Upgrade
EV/EBIT Ratio
37.8233.2987.6729.4110.15-
Upgrade
EV/FCF Ratio
41.32115.23468.6127.0911.24-
Upgrade
Debt / Equity Ratio
0.170.080.090.250.010.01
Upgrade
Debt / EBITDA Ratio
2.921.093.791.560.010.02
Upgrade
Debt / FCF Ratio
5.445.9929.481.670.020.01
Upgrade
Asset Turnover
0.240.260.270.780.680.76
Upgrade
Inventory Turnover
1.712.242.533.221.311.09
Upgrade
Quick Ratio
1.472.653.091.577.407.34
Upgrade
Current Ratio
1.933.694.002.368.729.34
Upgrade
Return on Equity (ROE)
2.64%3.67%2.64%7.51%33.55%33.82%
Upgrade
Return on Assets (ROA)
1.73%2.34%1.54%4.52%18.69%18.99%
Upgrade
Return on Capital (ROIC)
1.88%2.52%1.69%5.40%20.57%20.77%
Upgrade
Return on Capital Employed (ROCE)
3.10%4.00%1.50%13.50%30.60%27.10%
Upgrade
Earnings Yield
1.99%2.51%1.01%1.88%8.27%-
Upgrade
FCF Yield
2.34%0.86%0.21%2.67%7.40%-
Upgrade
Dividend Yield
1.88%1.74%0.77%7.46%8.35%-
Upgrade
Payout Ratio
-50.09%92.54%21.42%54.95%-
Upgrade
Buyback Yield / Dilution
-20.41%-97.22%-51.54%41.13%-5.76%3.72%
Upgrade
Total Shareholder Return
-18.53%-95.48%-50.77%48.59%2.59%3.72%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.